Literature DB >> 16643177

Laparoscopic fundoplication in patients with an aperistaltic esophagus and gastroesophageal reflux.

D I Watson1, G G Jamieson, J R Bessell, P G Devitt.   

Abstract

A minority of patients with severe gastroesophageal reflux who present to surgeons for antireflux surgery have absent esophageal peristalsis when investigated before surgery with esophageal manometry. Some of these patients also have systemic sclerodema. While conventional wisdom suggests that these patients are at risk of a poor outcome if they proceed to fundoplication, some will have severe reflux symptoms, which are poorly controlled by medical therapy, and surgery will therefore offer the only chance of 'cure'. We performed this study to determine the outcome of laparoscopic fundoplication in the subset of patients with gastroesophageal reflux and an aperistaltic esophagus. From 1991 to 2003, the operative and follow-up details for all 1443 patients who underwent a laparoscopic fundoplication in our Departments have been prospectively collected on a database. These patients were then followed yearly using a standardized symptom assessment questionnaire. A subset of patients whose preoperative esophageal manometry demonstrated complete absence of esophageal body peristalsis and absent lower esophageal sphincter tone (aperistaltic esophagus) were identified from this database, and their outcome following laparoscopic fundoplication was determined. Twenty-six patients with an aperistaltic esophagus who underwent a laparoscopic fundoplication were identified. Six of these had a systemic connective tissue disease (scleroderma), and 20 had an aperistaltic esophagus without a systemic disorder. A Nissen fundoplication was performed in four patients, and an anterior partial fundoplication in 22. Follow-up extended up to 12 years (median, 6). A good overall symptomatic outcome was achieved in 88% at 1 year, 83% at 2 years and 93% at 5-12 years follow-up. Reflux symptoms were well controlled by surgery alone in 79% at 1 year, and 79% at 5-12 years. At 2 years, 87% were eating a normal diet. Two patients underwent further surgery - one at 1 week postoperatively for a tight esophageal hiatus, and one at 1 year for recurrent reflux. Patients with troublesome reflux and an aperistaltic esophagus can be effectively treated by laparoscopic fundoplication. An acceptable outcome will be achieved in the majority of patients.

Entities:  

Mesh:

Year:  2006        PMID: 16643177     DOI: 10.1111/j.1442-2050.2006.00547.x

Source DB:  PubMed          Journal:  Dis Esophagus        ISSN: 1120-8694            Impact factor:   3.429


  15 in total

1.  Value of preoperative esophageal function studies before laparoscopic antireflux surgery.

Authors:  Walter W Chan; Laura R Haroian; C Prakash Gyawali
Journal:  Surg Endosc       Date:  2011-03-18       Impact factor: 4.584

Review 2.  Role and safety of fundoplication in esophageal disease and dysmotility syndromes.

Authors:  Charles T Bakhos; Roman V Petrov; Henry P Parkman; Zubair Malik; Abbas E Abbas
Journal:  J Thorac Dis       Date:  2019-08       Impact factor: 2.895

3.  Surgical management of gastroesophageal reflux disease in patients with systemic sclerosis.

Authors:  Jingliang Yan; Andrew T Strong; Gautam Sharma; Scott Gabbard; Prashanti Thota; John Rodriguez; Matthew Kroh
Journal:  Surg Endosc       Date:  2018-02-12       Impact factor: 4.584

4.  EAES recommendations for the management of gastroesophageal reflux disease.

Authors:  Karl Hermann Fuchs; Benjamin Babic; Wolfram Breithaupt; Bernard Dallemagne; Abe Fingerhut; Edgar Furnee; Frank Granderath; Peter Horvath; Peter Kardos; Rudolph Pointner; Edoardo Savarino; Maud Van Herwaarden-Lindeboom; Giovanni Zaninotto
Journal:  Surg Endosc       Date:  2014-05-02       Impact factor: 4.584

Review 5.  Lung Transplantation in Patients With Systemic Sclerosis.

Authors:  Rupal J Shah; Francesco Boin
Journal:  Curr Rheumatol Rep       Date:  2017-05       Impact factor: 4.592

6.  Lung atelectasis secondary to massive esophageal dilation in a patient with scleroderma.

Authors:  Charles St-Arnaud; Nicole Bouchard; Luc Lanthier
Journal:  Can Respir J       Date:  2010 Jul-Aug       Impact factor: 2.409

7.  Gastroesophageal reflux disease and connective tissue disorders: pathophysiology and implications for treatment.

Authors:  Marco G Patti; Warren J Gasper; Piero M Fisichella; Ian Nipomnick; Francesco Palazzo
Journal:  J Gastrointest Surg       Date:  2008-09-03       Impact factor: 3.452

8.  Systemic sclerosis and reflux.

Authors:  John J Petronovich; Jonathan M Bock
Journal:  Ear Nose Throat J       Date:  2013 Apr-May       Impact factor: 1.697

Review 9.  Gastrointestinal manifestations of systemic sclerosis.

Authors:  Robyn Domsic; Kenneth Fasanella; Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

10.  Laparoscopic Nissen fundoplication in Korean patients with gastroesophageal reflux disease.

Authors:  Sang Kuon Lee; Eung Kook Kim
Journal:  Yonsei Med J       Date:  2009-02-24       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.